These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
304 related articles for article (PubMed ID: 25617495)
1. Repression of microRNA-130b by thyroid hormone enhances cell motility. Lin YH; Wu MH; Liao CJ; Huang YH; Chi HC; Wu SM; Chen CY; Tseng YH; Tsai CY; Chung IH; Tsai MM; Chen CY; Lin TP; Yeh YH; Chen WJ; Lin KH J Hepatol; 2015 Jun; 62(6):1328-40. PubMed ID: 25617495 [TBL] [Abstract][Full Text] [Related]
2. miR-345 inhibits tumor metastasis and EMT by targeting IRF1-mediated mTOR/STAT3/AKT pathway in hepatocellular carcinoma. Yu M; Xue H; Wang Y; Shen Q; Jiang Q; Zhang X; Li K; Jia M; Jia J; Xu J; Tian Y Int J Oncol; 2017 Mar; 50(3):975-983. PubMed ID: 28098858 [TBL] [Abstract][Full Text] [Related]
3. Thyroid hormone receptor represses miR-17 expression to enhance tumor metastasis in human hepatoma cells. Lin YH; Liao CJ; Huang YH; Wu MH; Chi HC; Wu SM; Chen CY; Tseng YH; Tsai CY; Chung IH; Wu TI; Tsai MM; Lin CD; Lin KH Oncogene; 2013 Sep; 32(38):4509-18. PubMed ID: 23912452 [TBL] [Abstract][Full Text] [Related]
4. Thyroid hormone regulation of miR-21 enhances migration and invasion of hepatoma. Huang YH; Lin YH; Chi HC; Liao CH; Liao CJ; Wu SM; Chen CY; Tseng YH; Tsai CY; Lin SY; Hung YT; Wang CJ; Lin CD; Lin KH Cancer Res; 2013 Apr; 73(8):2505-17. PubMed ID: 23442323 [TBL] [Abstract][Full Text] [Related]
5. [The expression and clinopathological significance of miR-130b in human hepatocellular carcinoma]. Xu Q; Cai W; Zhang M; Liu Q; Liu X Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Mar; 32(3):387-92. PubMed ID: 26927562 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-130b promotes proliferation and EMT-induced metastasis via PTEN/p-AKT/HIF-1α signaling. Chang RM; Xu JF; Fang F; Yang H; Yang LY Tumour Biol; 2016 Aug; 37(8):10609-19. PubMed ID: 26861561 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-130b promotes cell aggressiveness by inhibiting peroxisome proliferator-activated receptor gamma in human hepatocellular carcinoma. Tu K; Zheng X; Dou C; Li C; Yang W; Yao Y; Liu Q Int J Mol Sci; 2014 Nov; 15(11):20486-99. PubMed ID: 25387077 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-370 Regulates Cellepithelial-Mesenchymal Transition, Migration, Invasion, and Prognosis of Hepatocellular Carcinoma by Targeting GUCD1. He Y; He X Yonsei Med J; 2019 Mar; 60(3):267-276. PubMed ID: 30799589 [TBL] [Abstract][Full Text] [Related]
9. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway. Wang R; Yu Z; Chen F; Xu H; Shen S; Chen W; Chen L; Su Q; Zhang L; Bi J; Zeng W; Li W; Huang X; Wang Q Biomed Pharmacother; 2018 Jul; 103():1632-1642. PubMed ID: 29864952 [TBL] [Abstract][Full Text] [Related]
10. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells. Wu WL; Wang WY; Yao WQ; Li GD Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma. Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082 [TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis. Wang Y; Liu Z; Yao B; Li Q; Wang L; Wang C; Dou C; Xu M; Liu Q; Tu K Mol Cancer; 2017 Jul; 16(1):123. PubMed ID: 28716020 [TBL] [Abstract][Full Text] [Related]
13. The potential mechanism of miR-130b on promotion of the invasion and metastasis of hepatocellular carcinoma by inhibiting Notch-Dll1. Ou C; Peng NF; Li H; Peng YC; Li LQ J Recept Signal Transduct Res; 2020 Apr; 40(2):157-165. PubMed ID: 32019397 [No Abstract] [Full Text] [Related]
14. MicroRNA-708 is downregulated in hepatocellular carcinoma and suppresses tumor invasion and migration. Li G; Yang F; Xu H; Yue Z; Fang X; Liu J Biomed Pharmacother; 2015 Jul; 73():154-9. PubMed ID: 26211597 [TBL] [Abstract][Full Text] [Related]
15. Thyroid hormone-mediated regulation of lipocalin 2 through the Met/FAK pathway in liver cancer. Chung IH; Chen CY; Lin YH; Chi HC; Huang YH; Tai PJ; Liao CJ; Tsai CY; Lin SL; Wu MH; Chen CY; Lin KH Oncotarget; 2015 Jun; 6(17):15050-64. PubMed ID: 25940797 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-98 acts as a tumor suppressor in hepatocellular carcinoma via targeting SALL4. Zhou W; Zou B; Liu L; Cui K; Gao J; Yuan S; Cong N Oncotarget; 2016 Nov; 7(45):74059-74073. PubMed ID: 27677076 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo. He XX; Chang Y; Meng FY; Wang MY; Xie QH; Tang F; Li PY; Song YH; Lin JS Oncogene; 2012 Jul; 31(28):3357-69. PubMed ID: 22056881 [TBL] [Abstract][Full Text] [Related]
18. microRNA-146a inhibits cancer metastasis by downregulating VEGF through dual pathways in hepatocellular carcinoma. Zhang Z; Zhang Y; Sun XX; Ma X; Chen ZN Mol Cancer; 2015 Jan; 14():5. PubMed ID: 25608619 [TBL] [Abstract][Full Text] [Related]
19. Methylation-associated silencing of microRNA-129-3p promotes epithelial-mesenchymal transition, invasion and metastasis of hepatocelluar cancer by targeting Aurora-A. Cui S; Zhang K; Li C; Chen J; Pan Y; Feng B; Lu L; Zhu Z; Wang R; Chen L Oncotarget; 2016 Nov; 7(47):78009-78028. PubMed ID: 27793005 [TBL] [Abstract][Full Text] [Related]
20. Thyroid hormone receptor inhibits hepatoma cell migration through transcriptional activation of Dickkopf 4. Chi HC; Liao CH; Huang YH; Wu SM; Tsai CY; Liao CJ; Tseng YH; Lin YH; Chen CY; Chung IH; Wu TI; Chen WJ; Lin KH Biochem Biophys Res Commun; 2013 Sep; 439(1):60-5. PubMed ID: 23958302 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]